AQR Capital Management’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-9,860
| Closed | -$783K | – | 2333 |
|
|
2021
Q1 | $783K | Sell |
9,860
-39,904
| -80% | -$3.12M | ﹤0.01% | 1659 |
|
|
2020
Q4 | $3.91M | Sell |
49,764
-69,731
| -58% | -$4.09M | 0.01% | 860 |
|
|
2020
Q3 | $5.25M | Sell |
119,495
-23,704
| -17% | -$1.17M | 0.01% | 759 |
|
|
2020
Q2 | $6.18M | Buy |
143,199
+116,829
| +443% | +$4.36M | 0.01% | 733 |
|
|
2020
Q1 | $947K | Buy |
+26,370
| New | +$1.5M | ﹤0.01% | 1359 |
|
|
2019
Q2 | – | Sell |
-19,257
| Closed | -$1.29M | – | 2232 |
|
|
2019
Q1 | $1.29M | Sell |
19,257
-59,390
| -76% | -$4.5M | ﹤0.01% | 1478 |
|
|
2018
Q4 | $5.86M | Sell |
78,647
-86,894
| -52% | -$7.17M | 0.01% | 901 |
|
|
2018
Q3 | $15.2M | Buy |
165,541
+117,785
| +247% | +$11.2M | 0.01% | 650 |
|
|
2018
Q2 | $4.7M | Buy |
47,756
+24,723
| +107% | +$2.77M | ﹤0.01% | 1056 |
|
|
2018
Q1 | $2.57M | Buy |
23,033
+18,964
| +466% | +$2.13M | ﹤0.01% | 1242 |
|
|
2017
Q4 | $419K | Sell |
4,069
-2,728
| -40% | -$272K | ﹤0.01% | 1975 |
|
|
2017
Q3 | $640K | Sell |
6,797
-4,497
| -40% | -$355K | ﹤0.01% | 1851 |
|
|
2017
Q2 | $880K | Sell |
11,294
-9,560
| -46% | -$718K | ﹤0.01% | 1714 |
|
|
2017
Q1 | $1.67M | Sell |
20,854
-14,155
| -40% | -$1.12M | ﹤0.01% | 1461 |
|
|
2016
Q4 | $2.76M | Sell |
35,009
-6,812
| -16% | -$529K | ﹤0.01% | 1264 |
|
|
2016
Q3 | $3.26M | Buy |
41,821
+9,378
| +29% | +$680K | 0.01% | 1180 |
|
|
2016
Q2 | $2.23M | Buy |
32,443
+9,815
| +43% | +$677K | ﹤0.01% | 1250 |
|
|
2016
Q1 | $1.61M | Sell |
22,628
-72
| -0.3% | -$4.52K | ﹤0.01% | 1360 |
|
|
2015
Q4 | $1.41M | Sell |
22,700
-24
| -0.1% | -$1.46K | ﹤0.01% | 1424 |
|
|
2015
Q3 | $1.29M | Sell |
22,724
-2,569
| -10% | -$136K | ﹤0.01% | 1315 |
|
|
2015
Q2 | $1.36M | Buy |
25,293
+1,050
| +4% | +$51.1K | ﹤0.01% | 1359 |
|
|
2015
Q1 | $1.15M | Sell |
24,243
-9,691
| -29% | -$429K | ﹤0.01% | 1353 |
|
|
2014
Q4 | $1.47M | Sell |
33,934
-21,109
| -38% | -$862K | ﹤0.01% | 1456 |
|
|
2014
Q3 | $1.89M | Sell |
55,043
-10,250
| -16% | -$362K | 0.01% | 1295 |
|
|
2014
Q2 | $2.39M | Buy |
65,293
+800
| +1% | +$27.1K | 0.01% | 1198 |
|
|
2014
Q1 | $2.17M | Buy |
64,493
+400
| +0.6% | +$13.2K | 0.01% | 1255 |
|
|
2013
Q4 | $2.17M | Sell |
64,093
-4,950
| -7% | -$171K | 0.01% | 1308 |
|
|
2013
Q3 | $2.2M | Sell |
69,043
-10,051
| -13% | -$267K | 0.01% | 1233 |
|
|
2013
Q2 | $1.79M | Buy |
+79,094
| New | +$1.71M | 0.01% | 1310 |
|
AQR Capital Management's CMD Position: Q2 2021 in Review
AQR Capital Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 9,860 shares — an estimated $783K sold.
AQR Capital Management first reported a position in CMD in Q2 2013 and held it in 29 quarters. The position peaked at $15.2M in Q3 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- AQR Capital Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- AQR Capital Management sold 9,860 Cantel Medical Corporation shares in Q2 2021, an estimated $783K.
- AQR Capital Management first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 29 quarters.
- AQR Capital Management's Cantel Medical Corporation position peaked at $15.2M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on AQR Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.